Connor, Clark & Lunn Investment Management Ltd.
Position in MDGL — Madrigal Pharmaceuticals, Inc.
CIK 1596800
VANCOUVER, A1
Position in MDGL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$956,844
-$13,667,337 QoQ
Shares Held
1,782
-93.6% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#201
of 411 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Connor, Clark & Lunn Investment Management Ltd. holds $650,455,383 across 105 Biotechnology names. MDGL ranks #65 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
135,236 | $67,175,777 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
684,236 | $54,253,072 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
625,569 | $50,990,129 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
420,063 | $49,176,775 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
42,465 | $26,478,625 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
97,698 | $23,913,539 | |
| 7 | INSM |
INSMED Inc
|
212,676 | $22,675,515 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
530,607 | $20,698,979 |
All Filings in MDGL
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $956,844 | 1,782 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $14,624,181 | 27,937 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $33,947,510 | 58,295 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $39,340,644 | 85,773 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $30,292,750 | 100,095 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $33,904,702 | 102,360 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $31,871,578 | 103,288 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $15,297,454 | 72,083 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $23,270,649 | 83,062 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $24,994,142 | 93,597 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $12,519,277 | 54,107 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $7,548,223 | 51,686 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $15,190,791 | 65,761 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $16,634,540 | 68,664 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $17,533,131 | 60,407 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,624,035 | 24,989 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $481,375 | 6,725 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $328,603 | 3,349 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $376,669 | 4,445 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $205,379 | 2,574 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||